Anifrolumab

Tax included
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research.
MedChemExpress 
HY-P99168

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
COVID-19-immunoregulation
CAS
1326232-46-5